Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

1.7K
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

4.9K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

374
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
374
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

769
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
769
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

732
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

332
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
332

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperconcentrated mucus in small airways: a mechanistic model for the pathogenesis of paediatric bronchiectasis.

European respiratory review : an official journal of the European Respiratory Society·2025
Same author

Early Diagnosis of Non-Cystic Fibrosis Bronchiectasis in Childhood: Shedding Light on Barriers and Opportunities.

Pediatric pulmonology·2025
Same author

[Ambroxol: mechanisms of action and efficacy for inhaled therapy in the treatment of respiratory diseases].

Recenti progressi in medicina·2025
Same author

First results from the international paediatric bronchiectasis registry (Child-BEAR-Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross-sectional study.

The Lancet. Respiratory medicine·2025
Same author

Cough in non-cystic fibrosis bronchiectasis.

ERJ open research·2024
Same author

The potential effects of climate change on non-cystic fibrosis bronchiectasis in children.

Paediatric respiratory reviews·2024

Related Experiment Video

Updated: Apr 1, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.5K

Update on Pediatric Cough.

Ahmad Kantar1

  • 1Pediatric Asthma and Cough Centre, Istituti Ospedalieri Bergamaschi, University and Research Hospitals, via Forlanini 15, Ponte San Pietro-Bergamo, 24036, Bergamo, Italy. kantar@centropediatricotosse.com.

Lung
|October 13, 2015
PubMed
Summary
This summary is machine-generated.

Pediatric chronic cough research is limited, but new findings highlight protracted bacterial bronchitis as a key cause in young children. This understanding is improving diagnosis and treatment for childhood cough.

Keywords:
ChildrenChronic coughCough etiologyProtracted bacterial bronchitis

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.9K
Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

1.4K

Related Experiment Videos

Last Updated: Apr 1, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.5K
Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.9K
Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

1.4K

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Immunology

Background:

  • Chronic cough in children is prevalent but under-researched, with unique pediatric characteristics often overlooked by non-specialists.
  • Childhood development involves significant maturation of the respiratory and nervous systems, impacting the cough reflex.
  • Infections and congenital issues are primary drivers of cough in children due to their developing immune systems.

Purpose of the Study:

  • To review the current understanding of chronic cough in children.
  • To highlight the evolving etiology of pediatric chronic cough.
  • To discuss emerging research in treatment and prevention.

Main Methods:

  • Literature review focusing on recent research in pediatric chronic cough.
  • Analysis of the developmental factors influencing cough reflex in children.
  • Examination of the shift from adult-based approaches to child-specific etiological considerations.

Main Results:

  • Protracted bacterial bronchitis is identified as a significant cause of chronic cough in preschool children.
  • This condition is increasingly recognized as a potential precursor to bronchiectasis.
  • Research is actively exploring new treatment and prevention strategies.

Conclusions:

  • Pediatric chronic cough requires a distinct approach from adult cough due to developmental differences.
  • Protracted bacterial bronchitis is a critical focus for understanding and managing chronic cough in young children.
  • Ongoing research promises advancements in managing and preventing childhood cough.